FIELD: pharmacology. SUBSTANCE: invention relates to treatment of diseases, whose pathogenesis mechanisms have, as primary biochemical steps, release of histamine from its depot and/or hyperactivation of free-radical process. Invention proposes use of gamma- glutamylhistamine in doses from 0.01 to 250 mg per 1 kg body weight. Preparation is nontoxic and is characterized by considerable spectrum of therapeutic action. EFFECT: enabled combination of immunocorrecting, antiallergic, wound- healing, anti-inflammatory, and antioxidant effects. 5 cl, 15 dwg, 7 tbl
Title | Year | Author | Number |
---|---|---|---|
METHOD OF SYNTHESIS OF GAMMA-L-GLUTAMYLHISTAMINE, USE OF GAMMA-L-GLUTAMYLHISTAMINE, PHARMACEUTICAL COMPOSITION | 1997 |
|
RU2141968C1 |
4-OXO-1,4-DIHYDROPYRIMIDINE DERIVATIVES HAVING ANTIALLERGIC AND IMMUNOTROPIC ACTIVITY | 1992 |
|
RU2015975C1 |
ANTIALLERGIC AGENT | 2006 |
|
RU2324491C1 |
2-(4-HYDROXY-3-METHOXY) STYRYLCHROMONE HAVING ANTIHYPOXIC, HYPERTENSIVE AND ANTIALLERGIC ACTIVITIES | 1990 |
|
SU1732656A1 |
N-ACYL DERIVATIVES OF AMINOACIDS, THEIR PHARMACEUTICALLY ACCEPTABLE SALTS, PHARMACEUTICAL COMPOSITION AND APPLICATION AS HYPOLIPIDEMIC PREPARATIONS | 2005 |
|
RU2335495C2 |
METHOD OF PRODUCING N-ACYL DERIVATIVES OF AMINO ACIDS (VERSIONS) | 2008 |
|
RU2378284C2 |
2-HYDROXY-3-METHOXYBENZALDEHYDE ISONICOTINOYL HYDRAZONE SHOWING ANTIASTHMATIC, ANTI-INFLAMMATORY AND ANTI-ALLERGIC ACTIVITY | 1997 |
|
RU2139711C1 |
PEPTIDE DERIVATIVES OR THEIR PHARMACEUTICALLY ACCEPTABLE SALTS, METHOD OF THEIR SYNTHESIS, USE AND PHARMACEUTICAL COMPOSITION | 1997 |
|
RU2141483C1 |
PHARMACEUTICAL COMPOSITION, CONTAINING N-ACYL DERIVATIVES OF AMINO ACIDS, AND THEIR APPLICATION AS ANTI-ALLERGIC, ANTI-ANAPHYLACTIC AND ANTI-INFLAMMATORY MEDICATIONS | 2008 |
|
RU2406727C2 |
4-IMINOCHROMEN DERIVATIVES HAVING ANTIHYPOXIC, HYPOTENSIVE AND ANTILALLERGIC ACTIVITIES | 1990 |
|
SU1746675A1 |
Authors
Dates
2002-03-27—Published
1999-01-12—Filed